Latest filing published 26 May 2026 for Beta Bionics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Maria Palasis is a declared insider at 2 companies; the most frequent names are Beta Bionics, Inc. and Lyra Therapeutics, Inc. We count 12 filings; the first trade dates from 16 October 2024 and the latest from 21 May 2026.
The open-market record consists of 6 sales worth €85k, with no purchase. Other entries cover 5 share grants. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 26 May 2026, the filings show a share grant in Beta Bionics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations